Methadone is an opioid agonist medication that has been used to treat opioid use disorder (OUD) for 50 years. Methadone reduces opioid craving and withdrawal and blunts or blocks the effects of opioids. As with all medications used in medications for addiction treatment (MAT), methadone is prescribed as part of a comprehensive treatment plan.
Methadone, which is also used to treat pain, can cause adverse effects, including overdose, if not taken as prescribed. By law, patients taking methadone to treat OUD must receive the medication under the supervision of a physician, and methadone is only dispensed through a SAMHSA-certified opioid treatment program (OTP).
Related Training Resources
Administrative Staff, Counselors, Judges, Nurses, PAs, Pharmacists, Pharmacy Technicians, Physicians, Psychiatrists, Psychologists, Social Workers
Credit Available:
CE Credit(s): No
Certificate: No
This manual provides guidelines for operating an opioid treatment program. It covers patient-centered care planning, assessment, admission, and monitoring; medication administration and use; medical and clinical provisions and practices; certification and accreditation; and the importance of practitioner judgment in providing care.
Presenter(s):
Brian Fuehrlein, MD, PhD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hour(s), Pharmacy CE Credit, AAPA Category 1 CME Credit, Social Work CE Credit, and IPCE Credit
Provides a basic introduction of the concepts of the disease of addiction and the role of the reward system. Using neuroscience concepts as a foundation, clinical manifestations of the disease of addiction are then discussed in the form of case-based presentations.
SUD101, 12 Step Programs, Acamprosate, Acute Pain, Agonist / Partial Agonist Withdrawal, Alcohol, Alcohol, Alcohol, Amphetamines, Antagonist ...
Presenter(s):
Brian Fuehrlein, MD, PhD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hour(s), Pharmacy CE Credit, AAPA Category 1 CME Credit, Social Work CE Credit, and IPCE Credit
Outlines the basic concepts of alcohol and drug use disorders. Standard drink sizes, screening for alcohol use disorders and an introduction to alcohol withdrawal management are discussed. A basic overview of the major drug use disorders are then discussed in a clinically-relevant manner.
SUD101, 12 Step Programs, Acamprosate, Acute Pain, Agonist / Partial Agonist Withdrawal, Alcohol, Alcohol, Alcohol, Amphetamines, Antagonist ...
Presenter(s):
Brian Fuehrlein, MD, PhD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hour(s), Pharmacy CE Credit, AAPA Category 1 CME Credit, Social Work CE Credit, and IPCE Credit
Provides an overview of the history of opioid use with an overview of contributing factors to the current epidemic. Using clinical cases, opioid use disorder is then discussed in detail. Finally, there is a discussion of harm reduction approaches and treatment options.
SUD101, 12 Step Programs, Acamprosate, Acute Pain, Agonist / Partial Agonist Withdrawal, Alcohol, Alcohol, Alcohol, Amphetamines, Antagonist ...
Presenter(s):
Brian Fuehrlein, MD, PhD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hour(s), Pharmacy CE Credit, AAPA Category 1 CME Credit, Social Work CE Credit, and IPCE Credit
Introduces evidence-based clinical practices of pharmacotherapy and behavioral treatments for substance use disorders. Off label medications and psychosocial support programs are also discussed.
Presenter(s):
Alexander Walley, MD, MSc
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hour(s), Pharmacy CE Credit, AAPA Category 1 CME Credit, Social Work CE Credit, and IPCE Credit
This webinar provides essential insights into addressing the opioid overdose crisis and improving substance use care. It equips healthcare providers with evidence-based strategies for overdose prevention, including naloxone distribution, and explores innovative approaches to engage at-risk populations. Key topics include the role of substance use care providers and new methods to reduce overdose deaths.
Administrative Staff, Counselors, Interprofessional Teams, Nurses, PAs, Pharmacists, Physicians, Psychologists, Social Workers
Presenter(s):
Daniel Rosa, MD, FASAM
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME, Social Work CE Credit, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
As the opioid use crisis continues to progress, communities across the country are now being faced with additional dangers such as the misuse of Xylazine, a powerful sedative commonly used for animals in the drug supply. Recent studies indicate these potent substances when used with opioids increase overdose risk and complicates treatment and long-term healthcare. Join us today as we discuss the history and context of Xylazine and opioid use as well as options for treatment and care.
Pharmacology, Antagonist, Buprenorphine, Buprenorphine, Full Agonists, Medications, Methadone, Methadone, Naloxone, Naltrexone ...
Credit Available:
CE Credit(s): No
Certificate: No
Shared decision-making (SDM) involves a collaborative discussion between the patient and clinician about treatment options, advantages and disadvantages, and helps to identify the optimal treatment based on patient-specific needs and goals.and helps to identify the optimal treatment based on patient-specific needs and goals.
Administrative Staff, Counselors, Family and Patient, Interprofessional Teams, Judges, Nurses, PAs, Pharmacists, Physicians, Psychiatrists, Social Workers
Presenter(s):
Darrell Mitchell, Founder of INARR, President of NARR, Vice President of Recovery Communities at Aspire Indiana Health, and Executive Director of Progress House
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME, Social Work CE Credit, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Despite significant evidence of their effectiveness and efficacy, individuals across the country are still facing barriers to care associated with the stigma surrounding medications for opioid use disorder (MOUD). One recent peer-reviewed study found that of 360 facilities supporting individuals with opioid-related needs, one fourth were unwilling to serve individuals receiving MOUD (Kepple et al., 2019). For those seeking recovery housing, this unwillingness can mean choosing between their life-saving medications and a safe, supportive place to live.
Counselors, Interprofessional Teams, Nurses, PAs, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators
Presenter(s):
Robert Sherrick, MD and Kathryn M. Basques, MSW, MSN, APN, PMHNP-BC
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on Hospital Based Approaches to OUD and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.
Loading more
